Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: A systematic review of published data

CNS Spectrums

Volumn 22, Issue 3, 2017, Pages 273-281

  Gentile, Salvatore ^a,b   Fusco, Maria Luigia ^c,d  

^a Azienda Sanitaria di Salerno   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Mental Health Center   (Italy)

^d Post graduate School of Psychology (SIPGI)   (Italy)

Author keywords

Antipsychotics; neurodevelopmental teratogenicity; neuroleptics; pregnancy; safety

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZIPRASIDONE; ZUCLOPENTHIXOL DECANOATE;

COGNITION; EMOTION; HUMAN; INFANT; INTERPERSONAL COMMUNICATION; LANGUAGE; META ANALYSIS; NERVE CELL DIFFERENTIATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUBLISHING; REVIEW; SOCIAL COMPETENCE; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; FEMALE; NEURODEVELOPMENTAL DISORDERS; PRENATAL EXPOSURE;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; INFANT; NEURODEVELOPMENTAL DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84995767428     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852916000699     Document Type: Review

References (44)

1. Gentile S. SSRIs in pregnancy and lactation with emphasis on neurodevelopmental outcome. CNS Drugs. 2005; 19(7): 623-633.
2. Gentile S. Bipolar disorder and pregnancy: to treat or not to treat? Br Med J. 2012; 345: e7367.
3. Toh S, Li Q, Cheetham TC, et al. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013; 16(2): 149-157.
4. Hanley GE, Mintzes B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth. 2014; 14: 242.
5. Epstein RA, Bobo WV, Shelton RC, et al. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf. 2013; 22(7): 794-801.
6. Barbui C, Conti V, Purgato M, et al. Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. Epidemiol Psychiatr Sci. 2013; 22(4): 355-361.
7. Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010; 36(3): 518-544.
8. Center for Disease Control and Prevention. Important milestones: your baby at four months. http://www.cdc.gov/ncbddd/actearly/ milestones/milestones-4mo.html. January 21, 2016. Accessed March 6, 2016.
9. GRADE working group. Criteria for applying or using GRADE. Update 2016. http://www.gradeworkinggroup.org/intro. htm#criteria. Accessed April 15, 2016.
10. Uguz F. Breastfed infants exposed to combined antipsychotics: two case-reports. Am J Ther. 2015; [Epub ahead of print]. DOI:10.1097/ MJT.0000000000000376.
11. Mervak B, Collins J, Valenstein M. Case report of aripiprazole usage during pregnancy. Arch Womens Ment Health. 2008; 11(3): 249-250.
12. Mendhekar DN, Sharma JB, Srilakshmi P. Use of aripiprazole during late pregnancy in a woman with psychotic illness. Ann Pharmacother. 2006; 40(3): 575.
13. Stoner SC, Sommi RW Jr, Marken PA, Anya I, Vaughn J. Clozapine use in two full-term pregnancies. J Clin Psychiatry. 1997; 58(8): 364-365.
14. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci. 2007; 19(2): 196-197.
15. Kirchheiner J, Berghöfer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry. 2000; 33(2): 78-80.
16. Burt VK, Bernstein C, Rosenstein WS, Altshuler LL. Bipolar disorder and pregnancy: maintaining psychiatric stability in the real world of obstetric and psychiatric complications. Am J Psychiatry. 2010; 167(8): 892-897.
17. Stiegler A, Schaletzky R, Walter G, et al. Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness? Psychopharmacology (Berl). 2014; 231(15): 3067-3069.
18. Rowe M, Gowda BA, Taylor D, Hannam S, Howard LM. Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report. Ther Adv Psychopharmacol. 2012; 2(6): 265-268.
19. Ifteni P, Moga MA, Burtea V, Correll CU. Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report. Ther Clin Risk Manag. 2014; 10: 901-904.
20. Malek-Ahmadi P. Olanzapine in pregnancy. Ann Pharmacother. 2001; 35(10): 1294-1295.
21. McCauley-Elsom KM, Cross W, Kulkarni J. Mental health: outcomes of 10 babies of mothers with a history of serious mental illness. J Psychiatr Ment Health Nurs. 2014; 21(7): 580-586.
22. Mendhekar D, Lohia D. Risperidone therapy in two successive pregnancies. J Neuropsychiatry Clin Neurosci. 2008; 20(4): 485-486.
23. Kim SW, Kim KM, Kim JM, et al. Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 543-545.
24. Yeong CC, Worsley R, Gilbert H, Kulkarni J. Gestational diabetes in women with mental illness. Aust N Z J Psychiatry. 2014; 48(10): 958.
25. Özdemir AK, Pak ŞC, Canan F, Geçici Ö, Kuloǧlu M, Gücer MK. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health. 2015; 18(5): 739-740.
26. Klier MC, Mossaheb N, Saria A, Schloegelhofer M, Zernig G. Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. J Clin Psychopharmacol. 2007; 27(6): 720-722.
27. Misri S, Corral M, Wardrop AA, Kendrick KK. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol. 2006; 26(5): 508-511.
28. Lee A, Giesbrecht E, Dunn E, Ito S. Excretion of quetiapine in breast milk. Am J Psychiatry. 2004; 161(9): 1715-1716.
29. Gentile S. Pharmacological management of borderline personality disorder in a pregnant woman with a previous history of alcohol addiction: a case report. Clin Drug Investig. 2015; 35(11): 761-763.
30. Grover S, Madan R. Successful use of quetiapine in two successive pregnancies. J Neuropsychiatry Clin Neurosci. 2012; 24(1): E38.
31. Werremeyer A. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. Am J Psychiatry. 2009; 166 (11): 1298.
32. Mendhekar DM, Andrade C. Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies. Arch Womens Ment Health. 2011; 14(1): 83-84.
33. Janjić V, Milovanović DR, Zecević DR, et al. Zuclopenthixol decanoate in pregnancy: successful outcomes in two consecutive offspring of the same mother. Vojnosanit Pregl. 2013; 70(5): 526-529.
34. Štika L, Elisová K, Honzáková H, et al. Effects of drug administration in pregnancy on children's school behaviour. Pharm Weekbl Sci. 1990; 12(6): 252-255.
35. Peng M, Gao K, Ding Y, et al. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl). 2013; 228(4): 577-584.
36. Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012; 69(8): 787-794.
37. Wichman CL. Atypical antipsychotic use in pregnancy: a retrospective review. Arch Womens Ment Health. 2009; 12(1): 53-57.
38. Walker A, Rosemberg M, Balaban-Gil K. Neurodevelopmental and neurobehavioral sequelae of selected substances of abuse and psychiatric medications in utero. Child Adolesc Psychiatr Clin N Am. 1999; 8(4): 845-867.
39. Lobstein R, Koren G. Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience. J Psychiatry Neurosci. 1997; 22(3): 192-196.
40. Scott JR. In defense of case reports. Obstet Gynecol. 2009; 114(2 Pt2): 413-414.
41. Hurd WW. Case reports in the era of evidence-based medicine. Obstet Gynecol. 2014;2 Pt 2; 124: 409-410.
42. Galbally M, Snellen M, Power J. Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf. 2014; 5(2): 100-109.
43. Morgan VA, Croft ML, Valuri GM, et al. Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression. Br J Psychiatry. 2012; 200(4): 282-289.
44. Ladavac AS, Dubin WR, Ning A, Stuckeman PA. Emergency management of agitation in pregnancy. Gen Hosp Psychiatry. 2007; 29(1): 39-41.